Skip to main content
Top
Published in: Cancer Causes & Control 10/2023

Open Access 19-06-2023 | Sarcoma | Brief Report

Birth characteristics and risk of Ewing sarcoma

Authors: Joseph L. Wiemels, Rong Wang, Qianxi Feng, Amy C. Yee, Libby M. Morimoto, Catherine Metayer, Xiaomei Ma

Published in: Cancer Causes & Control | Issue 10/2023

Login to get access

Abstract

Purpose

The incidence of Ewing sarcoma varies according to race and ethnicity, and genetic susceptibility is known to affect disease risk. Apart from these factors, the etiology of Ewing sarcoma is largely unknown.

Methods

We compared the birth characteristics of a population-based series of 556 Ewing sarcoma cases born in California in 1978–2015 and diagnosed in 1988–2015 with those of 27,800 controls selected from statewide birth records and frequency-matched to cases on the year of birth, using multivariable logistic regression models. We also assessed whether Ewing sarcoma clustered within families.

Results

Compared to non-Hispanic White subjects, Black (odds ratio [OR] = 0.07, 95% confidence interval [CI] 0.03–0.18), Asian (OR = 0.57, 95% CI 0.41–0.80), and Hispanic (OR = 0.73, 95% CI 0.62–0.88) individuals had a significantly lower risk of Ewing sarcoma. Race and ethnicity differences were more profound for metastatic Ewing sarcoma. Birthweight was also identified as a significant risk factor (OR = 1.09, 95% CI 1.00–1.18 for each 500 g increase in birthweight). A separate family-based cancer clustering analysis did not suggest any strong role for familial predisposition alleles.

Conclusions

This population-based study with minimal selection bias provides support for a role of accelerated fetal growth in the etiology of Ewing sarcoma in addition to more precise estimates of racial and ethnic variations in disease risk. This comparatively large analysis of birth characteristics and Ewing sarcoma in a multiethnic population should stimulate further investigations into genetic and environmental causes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519CrossRefPubMed Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519CrossRefPubMed
2.
go back to reference Hamilton SN, Carlson R, Hasan H, Rassekh SR, Goddard K (2017) Long-term outcomes and complications in pediatric ewing sarcoma. Am J Clin Oncol 40:423–428CrossRefPubMed Hamilton SN, Carlson R, Hasan H, Rassekh SR, Goddard K (2017) Long-term outcomes and complications in pediatric ewing sarcoma. Am J Clin Oncol 40:423–428CrossRefPubMed
3.
go back to reference Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG (2010) Ethnic and racial differences in patients with Ewing sarcoma. Cancer 116:983–988CrossRefPubMed Worch J, Matthay KK, Neuhaus J, Goldsby R, DuBois SG (2010) Ethnic and racial differences in patients with Ewing sarcoma. Cancer 116:983–988CrossRefPubMed
4.
go back to reference Chen S, Yang L, Pu F et al (2015) High birth weight increases the risk for bone tumor: a systematic review and meta-analysis. Int J Environ Res Public Health 12:11178–11195CrossRefPubMedPubMedCentral Chen S, Yang L, Pu F et al (2015) High birth weight increases the risk for bone tumor: a systematic review and meta-analysis. Int J Environ Res Public Health 12:11178–11195CrossRefPubMedPubMedCentral
6.
go back to reference Surveillance E, and End Results (SEER) Program (2018) SEER*Stat database: incidence SEER 9 Regs Research Data, Nov 2018 Sub (1975–2016). In: National Cancer Institute D, Surveillance Research Program ed Surveillance E, and End Results (SEER) Program (2018) SEER*Stat database: incidence SEER 9 Regs Research Data, Nov 2018 Sub (1975–2016). In: National Cancer Institute D, Surveillance Research Program ed
7.
go back to reference Fraumeni JF Jr, Glass AG (1970) Rarity of Ewing’s sarcoma among U.S. Negro children. Lancet 1:366–367CrossRefPubMed Fraumeni JF Jr, Glass AG (1970) Rarity of Ewing’s sarcoma among U.S. Negro children. Lancet 1:366–367CrossRefPubMed
8.
9.
go back to reference Machiela MJ, Grunewald TGP, Surdez D et al (2018) Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nat Commun 9:3184CrossRefPubMedPubMedCentral Machiela MJ, Grunewald TGP, Surdez D et al (2018) Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility. Nat Commun 9:3184CrossRefPubMedPubMedCentral
10.
go back to reference Postel-Vinay S, Veron AS, Tirode F et al (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44:323–327CrossRefPubMed Postel-Vinay S, Veron AS, Tirode F et al (2012) Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat Genet 44:323–327CrossRefPubMed
11.
go back to reference Hu X, Fujiwara T, Houdek MT et al (2022) Impact of racial disparities and insurance status in patients with bone sarcomas in the USA: a population-based cohort study. Bone Jt Res 11:278–291CrossRef Hu X, Fujiwara T, Houdek MT et al (2022) Impact of racial disparities and insurance status in patients with bone sarcomas in the USA: a population-based cohort study. Bone Jt Res 11:278–291CrossRef
12.
go back to reference O’Neill KA, Murphy MF, Bunch KJ et al (2015) Infant birthweight and risk of childhood cancer: international population-based case control studies of 40 000 cases. Int J Epidemiol 44:153–168CrossRefPubMed O’Neill KA, Murphy MF, Bunch KJ et al (2015) Infant birthweight and risk of childhood cancer: international population-based case control studies of 40 000 cases. Int J Epidemiol 44:153–168CrossRefPubMed
Metadata
Title
Birth characteristics and risk of Ewing sarcoma
Authors
Joseph L. Wiemels
Rong Wang
Qianxi Feng
Amy C. Yee
Libby M. Morimoto
Catherine Metayer
Xiaomei Ma
Publication date
19-06-2023
Publisher
Springer International Publishing
Keyword
Sarcoma
Published in
Cancer Causes & Control / Issue 10/2023
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01737-4

Other articles of this Issue 10/2023

Cancer Causes & Control 10/2023 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine